{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:00:47Z","timestamp":1788177647670,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["108.05-2018.15"],"award-info":[{"award-number":["108.05-2018.15"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11030-022-10558-7","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T19:03:03Z","timestamp":1667329383000},"page":"2315-2330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of small molecules as potential inhibitors of interleukin 6: a multi-computational investigation"],"prefix":"10.1007","volume":"27","author":[{"given":"Que-Huong","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6315-2974","authenticated-orcid":false,"given":"Quoc-Thai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi-Thuy Nga","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh-Dao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Tri","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3886-3210","authenticated-orcid":false,"given":"Dieu-Thuong Thi","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4976-0436","authenticated-orcid":false,"given":"Van-Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet-Hung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-9614","authenticated-orcid":false,"given":"Khac-Minh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"10558_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.7150\/ijbs.59272","volume":"18","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Rubin L, Peng T, Liu L, Xing X, Lazarovici P, Zheng W (2022) Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy. Int J Biol Sci 18:459\u2013472. https:\/\/doi.org\/10.7150\/ijbs.59272","journal-title":"Int J Biol Sci"},{"key":"10558_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","volume":"29","author":"A Ogata","year":"2019","unstructured":"Ogata A, Kato Y, Higa S, Yoshizaki K (2019) IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol 29:258\u2013267. https:\/\/doi.org\/10.1080\/14397595.2018.1546357","journal-title":"Mod Rheumatol"},{"key":"10558_CR3","doi-asserted-by":"publisher","first-page":"e0244628","DOI":"10.1371\/journal.pone.0244628","volume":"15","author":"J Gorham","year":"2020","unstructured":"Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M, Izzi A, Nagant C, Djangang NN, Garufi A, Creteur J, Taccone FS (2020) Interleukine-6 in critically ill COVID-19 patients: a retrospective analysis. PLoS ONE 15:e0244628. https:\/\/doi.org\/10.1371\/journal.pone.0244628","journal-title":"PLoS ONE"},{"key":"10558_CR4","doi-asserted-by":"publisher","first-page":"118054","DOI":"10.1016\/j.lfs.2020.118054","volume":"257","author":"SM Abdin","year":"2020","unstructured":"Abdin SM, Elgendy SM, Alyammahi SK, Alhamad DW, Omar HA (2020) Tackling the cytokine storm in COVID-19, challenges and hopes. Life Sci 257:118054. https:\/\/doi.org\/10.1016\/j.lfs.2020.118054","journal-title":"Life Sci"},{"key":"10558_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H (2020) Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol 30:1\u20139. https:\/\/doi.org\/10.1002\/rmv.2141","journal-title":"Rev Med Virol"},{"key":"10558_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","volume":"22","author":"T Kishimoto","year":"2010","unstructured":"Kishimoto T (2010) IL-6: from its discovery to clinical applications. Int Immunol 22:347\u2013352. https:\/\/doi.org\/10.1093\/intimm\/dxq030","journal-title":"Int Immunol"},{"key":"10558_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-Jone S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813:878\u2013888. https:\/\/doi.org\/10.1016\/j.bbamcr.2011.01.034","journal-title":"Biochim Biophys Acta"},{"key":"10558_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/emboj\/16.5.989","volume":"16","author":"W Somers","year":"1997","unstructured":"Somers W, Stahl M, Seehra JS (1997) 1.9 \u00c5 crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. Embo J 16:989\u2013997. https:\/\/doi.org\/10.1093\/emboj\/16.5.989","journal-title":"Embo J"},{"key":"10558_CR9","doi-asserted-by":"publisher","first-page":"13846","DOI":"10.1074\/jbc.M115.695528","volume":"291","author":"C Blanchetot","year":"2016","unstructured":"Blanchetot C, Jonge ND, Desmyter A, Ongenae N, Hofman E, Klarenbeek A, Sadi A, Hultberg A, Kretz-Rommel A, Spinelli S, Loris R, Cambillau C, Haard HD (2016) Structural mimicry of receptor interaction by antagonistic interleukin-6 (IL-6) antibodies. J Biol Chem 291:13846\u201313854. https:\/\/doi.org\/10.1074\/jbc.M115.695528","journal-title":"J Biol Chem"},{"key":"10558_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","volume":"334","author":"PC Heinrich","year":"1998","unstructured":"Heinrich PC, Behrmann I, M\u00fcller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway. Biochem J 334:297\u2013314. https:\/\/doi.org\/10.1042\/bj3340297","journal-title":"Biochem J"},{"key":"10558_CR11","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/j.1460-2075.1995.tb07186.x","volume":"14","author":"G Paonessa","year":"1995","unstructured":"Paonessa G, Graziani R, Serio AD, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, Ciliberto G (1995) Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. Embo J 14:1942\u20131951. https:\/\/doi.org\/10.1002\/j.1460-2075.1995.tb07186.x","journal-title":"Embo J"},{"key":"10558_CR12","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1126\/science.1083901","volume":"300","author":"MJ Boulanger","year":"2003","unstructured":"Boulanger MJ, Chow DC, Brevnova EE, Garcia KC (2003) Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex. Science 300:2101\u20132104. https:\/\/doi.org\/10.1126\/science.1083901","journal-title":"Science"},{"key":"10558_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000341698","volume":"30","author":"A Chalaris","year":"2012","unstructured":"Chalaris A, Schmidt-Arras D, Yamamoto K, Rose-John S (2012) Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Dig Dis 30:492\u2013499. https:\/\/doi.org\/10.1159\/000341698","journal-title":"Dig Dis"},{"key":"10558_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrd.2018.45","volume":"17","author":"C Garbers","year":"2018","unstructured":"Garbers C, Heink S, Korn T, Rose-John S (2018) Interleukin-6: designing specific therapeutics for a complex cytokine. Nat Rev Drug Discov 17:395\u2013412. https:\/\/doi.org\/10.1038\/nrd.2018.45","journal-title":"Nat Rev Drug Discov"},{"key":"10558_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40290-020-00342-z","volume":"34","author":"S Atal","year":"2020","unstructured":"Atal S, Fatima Z (2020) IL-6 Inhibitors in the treatment of serious COVID-19: a promising therapy? Pharmaceut Med 34:223\u2013231. https:\/\/doi.org\/10.1007\/s40290-020-00342-z","journal-title":"Pharmaceut Med"},{"key":"10558_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/intimm\/dxab011","volume":"33","author":"T Kishimoto","year":"2021","unstructured":"Kishimoto T (2021) IL-6: from arthritis to CAR-T-cell therapy and COVID-19. Int Immunol 33:515\u2013519. https:\/\/doi.org\/10.1093\/intimm\/dxab011","journal-title":"Int Immunol"},{"key":"10558_CR17","doi-asserted-by":"publisher","first-page":"P518","DOI":"10.1016\/j.jaci.2020.07.001","volume":"146","author":"A Copaescu","year":"2020","unstructured":"Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA (2020) The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol 146:P518-534. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.001","journal-title":"J Allergy Clin Immunol"},{"key":"10558_CR18","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s11030-021-10359-4","volume":"26","author":"TT Mai","year":"2022","unstructured":"Mai TT, Nguyen PG, Le MT, Tran TD, Huynh PNH, Trinh DT, Nguyen QT, Thai KM (2022) Discovery of small molecular inhibitors for interleukin-33\/ST2 protein-protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations. Mol Divers 26:2659\u20132678. https:\/\/doi.org\/10.1007\/s11030-021-10359-4","journal-title":"Mol Divers"},{"key":"10558_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"XY Meng","year":"2012","unstructured":"Meng XY, Zhang HX, Mezei M, Cui M (2012) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146\u2013157. https:\/\/doi.org\/10.2174\/157340911795677602","journal-title":"Curr Comput Aided Drug Des"},{"key":"10558_CR20","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46:D1074-1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"key":"10558_CR21","unstructured":"Molecular Operating Environment (MOE) (2015) Version 2015.10. Chemical Computing Group Inc., Montreal"},{"key":"10558_CR22","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.V89.4.1319","volume":"89","author":"M Kalai","year":"1997","unstructured":"Kalai M, Montero-Julian FA, Gr\u00f6tzinger J, Fontaine V, Vandenbussche P, Deschuyteneer R, Wollmer A, Brailly H, Content J (1997) Analysis of the human interleukin-6\/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction. Blood 89:1319\u20131333","journal-title":"Blood"},{"key":"10558_CR23","unstructured":"The Protein Data Bank. https:\/\/www.rcsb.org\/structure\/4ZS7. Accessed 20 June 2021"},{"key":"10558_CR24","unstructured":"LeadIT. Version 2.1.8. https:\/\/www.biosolveit.de\/LeadIT. Accessed 15 Sep 2021"},{"key":"10558_CR25","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11030-016-9688-5","volume":"20","author":"TD Ngo","year":"2016","unstructured":"Ngo TD, Tran TD, Le MT, Thai KM (2016) Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds. Mol Divers 20:945\u2013961. https:\/\/doi.org\/10.1007\/s11030-016-9688-5","journal-title":"Mol Divers"},{"key":"10558_CR26","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.rechem.2021.100101","volume":"3","author":"PN Sekhar","year":"2021","unstructured":"Sekhar PN (2021) Computational prediction of hERG blockers using homology modelling, molecular docking and QuaSAR studies. Results Chem 3:100101. https:\/\/doi.org\/10.1016\/j.rechem.2021.100101","journal-title":"Results Chem"},{"key":"10558_CR27","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1021\/ci034243x","volume":"44","author":"JS Delaney","year":"2004","unstructured":"Delaney JS (2004) ESOL: estimating aqueous solubility directly from molecular structure. J Chem Inf Comput Sci 44:1000\u20131005. https:\/\/doi.org\/10.1021\/ci034243x","journal-title":"J Chem Inf Comput Sci"},{"key":"10558_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V (2016) A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11:1117\u20131121. https:\/\/doi.org\/10.1002\/cmdc.201600182","journal-title":"ChemMedChem"},{"key":"10558_CR29","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci Rep"},{"key":"10558_CR30","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.3390\/molecules25163644","volume":"25","author":"TS Tran","year":"2020","unstructured":"Tran TS, Le MT, Tran TD, Tran TH, Thai KM (2020) Design of curcumin and flavonoid derivatives with acetylcholinesterase and beta-secretase inhibitory activities using in silico approaches. Molecules 25:3644. https:\/\/doi.org\/10.3390\/molecules25163644","journal-title":"Molecules"},{"key":"10558_CR31","doi-asserted-by":"publisher","unstructured":"Lindahl E, Abraham MJ, Hess B, Spoel Dvd (2021) GROMACS 2021.02 Documentation (Release 2021.02). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4457591","DOI":"10.5281\/zenodo.4457591"},{"key":"10558_CR32","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1021\/jp973084f","volume":"102","author":"AD Mackerell","year":"1998","unstructured":"Mackerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Matto C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wi\u00f3rkiewicz-Kuczera J, Yin D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586\u20133616. https:\/\/doi.org\/10.1021\/jp973084f","journal-title":"J Phys Chem B"},{"key":"10558_CR33","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","journal-title":"J Comput Chem"},{"key":"10558_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 4:17. https:\/\/doi.org\/10.1186\/1758-2946-4-17","journal-title":"J Cheminform"},{"key":"10558_CR35","doi-asserted-by":"publisher","first-page":"e11261","DOI":"10.7717\/peerj.11261","volume":"9","author":"AK Bepari","year":"2021","unstructured":"Bepari AK, Reza HM (2021) Identification of a novel inhibitor of SARS-CoV-2 3CL-PRO through virtual screening and molecular dynamics simulation. PeerJ 9:e11261. https:\/\/doi.org\/10.7717\/peerj.11261","journal-title":"PeerJ"},{"key":"10558_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"10558_CR37","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s00894-014-2216-6","volume":"20","author":"PT Nguyen","year":"2014","unstructured":"Nguyen PT, Yu H, Keller PA (2014) Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus. J Mol Model 20:2216. https:\/\/doi.org\/10.1007\/s00894-014-2216-6","journal-title":"J Mol Model"},{"key":"10558_CR38","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Lynn A (2014) g_mmpbsa\u2013a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"key":"10558_CR39","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"10558_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/minf.201100135","volume":"31","author":"N Homeyer","year":"2012","unstructured":"Homeyer N, Gohlke H (2012) Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol Inform 31:114\u2013122. https:\/\/doi.org\/10.1002\/minf.201100135","journal-title":"Mol Inform"},{"key":"10558_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10:449\u2013461. https:\/\/doi.org\/10.1517\/17460441.2015.1032936","journal-title":"Expert Opin Drug Discov"},{"key":"10558_CR42","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/jcc.24839","volume":"38","author":"N Ch\u00e9ron","year":"2017","unstructured":"Ch\u00e9ron N, Shakhnovich EI (2017) Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations. J Comput Chem 38:1941\u20131951. https:\/\/doi.org\/10.1002\/jcc.24839","journal-title":"J Comput Chem"},{"key":"10558_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341. https:\/\/doi.org\/10.1016\/j.ddtec.2004.11.007","journal-title":"Drug Discov Today Technol"},{"key":"10558_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55\u201368. https:\/\/doi.org\/10.1021\/cc9800071","journal-title":"J Comb Chem"},{"key":"10558_CR45","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"10558_CR46","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorption using multivariate statistics. J Med Chem 43:3867\u20133877. https:\/\/doi.org\/10.1021\/jm000292e","journal-title":"J Med Chem"},{"key":"10558_CR47","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria for drug-like chemical matter. J Med Chem 44:1841\u20131846. https:\/\/doi.org\/10.1021\/jm015507e","journal-title":"J Med Chem"},{"key":"10558_CR48","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/1389203715666140327114232","volume":"15","author":"SA Ali","year":"2014","unstructured":"Ali SA, Hassan MI, Islam A, Ahmad F (2014) A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Curr Protein Pept Sci 15:456\u2013476. https:\/\/doi.org\/10.2174\/1389203715666140327114232","journal-title":"Curr Protein Pept Sci"},{"key":"10558_CR49","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva NS, Galzitskaya OV (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628. https:\/\/doi.org\/10.1134\/S0026893308040195","journal-title":"Mol Biol"},{"key":"10558_CR50","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1080\/07391102.2020.1835727","volume":"40","author":"HA Oyewusi","year":"2022","unstructured":"Oyewusi HA, Huyop F, Wahab RA (2022) Molecular docking and molecular dynamics simulation of Bacillus thuringiensis dehalogenase against haloacids, haloacetates and chlorpyrifos. J Biomol Struct Dyn 40:1979\u20131994. https:\/\/doi.org\/10.1080\/07391102.2020.1835727","journal-title":"J Biomol Struct Dyn"},{"key":"10558_CR51","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.2174\/092986710792232021","volume":"17","author":"A Lauria","year":"2010","unstructured":"Lauria A, Tutone M, Ippolito M, Pantano L, Almerico AM (2010) Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: the investigation of p53-MDM2 interaction and its inhibition by small molecules. Curr Med Chem 17:3142\u20133154. https:\/\/doi.org\/10.2174\/092986710792232021","journal-title":"Curr Med Chem"},{"key":"10558_CR52","doi-asserted-by":"publisher","first-page":"e0264385","DOI":"10.1371\/journal.pone.0264385","volume":"17","author":"TT Tran","year":"2022","unstructured":"Tran TT, Tran QH, Nguyen QT, Le MT, Trinh DT, Thai KM (2022) Identification of potential interleukin-8 inhibitors acting on the interactive site between chemokine and CXCR2 receptor: a computational approach. PLoS ONE 17:e0264385. https:\/\/doi.org\/10.1371\/journal.pone.0264385","journal-title":"PLoS ONE"},{"key":"10558_CR53","doi-asserted-by":"publisher","first-page":"e0266632","DOI":"10.1371\/journal.pone.0266632","volume":"17","author":"QH Tran","year":"2022","unstructured":"Tran QH, Nguyen QT, Vo NQ, Mai TT, Tran TT, Tran TD, Le MT, Trinh DT, Thai KM (2022) Structure-based 3D-Pharmacophore modeling to discover novel interleukin 6 inhibitors: an in silico screening, molecular dynamics simulations and binding free energy calculations. PLoS ONE 17:e0266632. https:\/\/doi.org\/10.1371\/journal.pone.0266632","journal-title":"PLoS ONE"},{"key":"10558_CR54","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.2174\/1568026611313090004","volume":"13","author":"KM Thai","year":"2013","unstructured":"Thai KM, Ngo TD, Tran TD, Le MT (2013) Pharmacophore Modeling for Antitargets. Curr Top Med Chem 13:1002\u20131014. https:\/\/doi.org\/10.2174\/1568026611313090004","journal-title":"Curr Top Med Chem"},{"key":"10558_CR55","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","volume":"24","author":"KK Mak","year":"2019","unstructured":"Mak KK, Pichika MR (2019) Artificial intelligence in drug development: present status and future prospects. Drug Discov Today 24:773\u2013780. https:\/\/doi.org\/10.1016\/j.drudis.2018.11.014","journal-title":"Drug Discov Today"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10558-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-022-10558-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-022-10558-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:46:12Z","timestamp":1744206372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-022-10558-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10558"],"URL":"https:\/\/doi.org\/10.1007\/s11030-022-10558-7","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"31 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}